Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.17
+0.79%
Mkt Cap $1.36B
EPS — Estimate vs Actual
Mkt Cap
$1.36B
P/E
—
Fwd P/E
—
P/S
20.51
Rev TTM
—
EPS TTM
-$1.20
NASDAQ·Healthcare·Biotechnology
$3.17
+0.79%
Mkt Cap $1.36B
Mkt Cap
$1.36B
P/E
—
Fwd P/E
—
P/S
20.51
Rev TTM
—
EPS TTM
-$1.20